trial summary · NCT07473700
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
An Open-Label Study to Assess the Hemodynamic Effect and the Safety of TX000045 After 16 Weeks of Treatment in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Trial record from the TrialBase DB dataset, status RECRUITING, condition Hypertension, Pulmonary, sponsored by Tectonic Operating Company, Inc.. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
The primary purpose of this study is to assess the effect of TX000045 on pulmonary vascular resistance (PVR) in participants with pulmonary hypertension secondary to interstitial lung disease (PH-ILD) and to assess the safety and tolerability of TX000045 in participants with PH-ILD.
Source record: https://clinicaltrials.gov/study/NCT07473700
Facts
| registry id | NCT07473700 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | PHASE2 |
| study type | INTERVENTIONAL |
| lead condition | Hypertension, Pulmonary |
| sponsor | Tectonic Operating Company, Inc. |
| sponsor class | INDUSTRY |
| enrollment | 25 |
| start date | 2026-10-30 |
| primary completion | 2027-11-21 |
| completion | 2027-12-11 |
| results posted | not reported |
Conditions
- Hypertension, Pulmonary
- Lung Diseases, Interstitial
Interventions
- TX000045
Countries
- Poland
- Romania
- Serbia
- South Korea
- Spain
- United States
Intervention types: DRUG
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.